Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Interesting news from the annual meeting of the American Society of Hematology 2020

Interesting news from the annual meeting of the American Society of Hematology 2020 editorial memo (2021) 14:215 https://doi.org/10.1007/s12254-021-00733-1 Interesting news from the annual meeting of the American Society of Hematology 2020 Eberhard Gunsilius Accepted: 7 July 2021 © Springer-Verlag GmbH Austria, part of Springer Nature 2021 The 62nd annual meeting of the American Society of gies, such as CAR-T cells and monoclonal antibodies Hematology, the most influential meeting in hematol- that recruit T-cells to the malignant cells (bispecific ogy, was held (formally in San Diego, CA, USA) as an T-cell enhancers [BITE]) are currently tested in clini- all-virtual meeting from December 5–8, 2020. Apart cal trials and show impressive clinical results even in from outstanding contributions “from the bench” with heavily pretreated patients and will enrich our ther- the potential to find a way into diagnosis and treat- apeutic armamentarium in the near future, although ment, a plethora of clinical trials, many in early clin- with considerable financial toxicity for the health care ical phase investigating novel compounds, were pre- systems. sented. In this issue of MEMO, selected presentations What we have missed are the personal contacts and that are relevant for our daily practice or are likely to discussions with friends and colleagues. We all hope become relevant in thenearfutureare highlightedby http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Interesting news from the annual meeting of the American Society of Hematology 2020

Interesting news from the annual meeting of the American Society of Hematology 2020

Abstract

editorial memo (2021) 14:215 https://doi.org/10.1007/s12254-021-00733-1 Interesting news from the annual meeting of the American Society of Hematology 2020 Eberhard Gunsilius Accepted: 7 July 2021 © Springer-Verlag GmbH Austria, part of Springer Nature 2021 The 62nd annual meeting of the American Society of gies, such as CAR-T cells and monoclonal antibodies Hematology, the most influential meeting in hematol- that recruit T-cells to the malignant cells (bispecific ogy, was...
Loading next page...
 
/lp/springer-journals/interesting-news-from-the-annual-meeting-of-the-american-society-of-YN5dCVHcPk

References (6)

Publisher
Springer Journals
Copyright
2021 Springer-Verlag GmbH Austria, part of Springer Nature
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-021-00733-1
Publisher site
See Article on Publisher Site

Abstract

editorial memo (2021) 14:215 https://doi.org/10.1007/s12254-021-00733-1 Interesting news from the annual meeting of the American Society of Hematology 2020 Eberhard Gunsilius Accepted: 7 July 2021 © Springer-Verlag GmbH Austria, part of Springer Nature 2021 The 62nd annual meeting of the American Society of gies, such as CAR-T cells and monoclonal antibodies Hematology, the most influential meeting in hematol- that recruit T-cells to the malignant cells (bispecific ogy, was held (formally in San Diego, CA, USA) as an T-cell enhancers [BITE]) are currently tested in clini- all-virtual meeting from December 5–8, 2020. Apart cal trials and show impressive clinical results even in from outstanding contributions “from the bench” with heavily pretreated patients and will enrich our ther- the potential to find a way into diagnosis and treat- apeutic armamentarium in the near future, although ment, a plethora of clinical trials, many in early clin- with considerable financial toxicity for the health care ical phase investigating novel compounds, were pre- systems. sented. In this issue of MEMO, selected presentations What we have missed are the personal contacts and that are relevant for our daily practice or are likely to discussions with friends and colleagues. We all hope become relevant in thenearfutureare highlightedby

Journal

memo - Magazine of European Medical OncologySpringer Journals

Published: Sep 1, 2021

Keywords: oncology; medicine/public health, general

There are no references for this article.